About Oxford Biomedical Research
Oxford Biomedical Research is a Healthcare company based in Rochester Hills (United States) founded in 1984. Products for oxidative stress, inflammation, and antioxidant assays are manufactured. Oxford Biomedical Research offers products and services including Assay Kits, Immunoassay Kit, CypExpress, and Antioxidant Measurement. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Oxford Biomedical Research was founded in 1984 and is based in Rochester Hills, United States. Operations focus on the biomedical research and drug discovery sectors, where biomarkers for oxidative stress and chronic inflammation are identified and assayed. A range of products, including ELISA kits, recombinant proteins, antibodies, and enzymes related to eicosanoid metabolism and vascular biology, is developed, manufactured, and marketed. Contract manufacturing services are also provided to customers.
- Headquarters Rochester Hills, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oxfordbiomed.com
- Social LinkedIn X Facebook
- Latest Funding Round$99.2K (USD), Grant
Jul 2021
- Investors
Products & Services of Oxford Biomedical Research
Oxford Biomedical Research offers a comprehensive portfolio of products and services, including Assay Kits, Immunoassay Kit, CypExpress, and Antioxidant Measurement.
Kits for measuring oxidative stress and inflammation in biological samples.
Quantifies isoprostanes in urine and saliva without derivatization.
System for P450 profiling and metabolite synthesis in research.
Tools for assessing antioxidants in various biological fluids.
Funding Insights of Oxford Biomedical Research
- Total Rounds 6
- Last Round Grant — $99,203
- First Round $1.16M
(Mar 2010)
- Investors Count 1
All 6 funding rounds of Oxford Biomedical Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Oxford Biomedical Research
Oxford Biomedical Research has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Oxford Biomedical Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oxford Biomedical Research
1 people are tracked at Oxford Biomedical Research (1 in leadership).
| Name | Role | Group |
|---|---|---|
Richard McGowen | President | Leadership |
Complete people profiles for Oxford Biomedical Research
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oxford Biomedical Research
3 dated milestones of Oxford Biomedical Research across 37 years, from founding to its latest funding, stage changes and deals.
- Founded Oxford Biomedical Research is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Grant, of $99K.
Competitors of Oxford Biomedical Research
Oxford Biomedical Research has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Oxford Biomedical Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Oxford Biomedical Research
The website of Oxford Biomedical Research (oxfordbiomed.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 16.5% vs previous month
Websites whose visitors overlap most with Oxford Biomedical Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioassaysys.com | 100% | 12.4K | #2,032,630 | View details | |
| mol-innov.com | 100% | View details | |||
| insphero.com | 100% | 16.2K | #1,384,057 | View details | |
| immunochemistry.com | 95% | View details | |||
| panomics.com | 92% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Oxford Biomedical Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Oxford Biomedical Research (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oxford Biomedical Research
Oxford Biomedical Research was founded in 1984 and raised its 1st funding round 26 years after it was founded.
Oxford Biomedical Research is headquartered in Rochester Hills, United States. It is registered at Rochester Hills, Michigan, United States.
Oxford Biomedical Research was founded in 1984 and is based in Rochester Hills, United States. Operations focus on the biomedical research and drug discovery sectors, where biomarkers for oxidative stress and chronic inflammation are identified and assayed. A range of products, including ELISA kits, recombinant proteins, antibodies, and enzymes related to eicosanoid metabolism and vascular biology, is developed, manufactured, and marketed. Contract manufacturing services are also provided to customers.
Oxford Biomedical Research's top competitors include GenScript, Epitomics and Vector Laboratories.
Oxford Biomedical Research offers Assay Kits, Immunoassay Kit, CypExpress, and Antioxidant Measurement.
Oxford Biomedical Research has 1 investor. Key investors include HHS.